Home Optovue


Optovue Receives FDA Clearance for AngioAnalytics – the World’s First OCT Angiography Metrics

6/11/18: “AngioAnalytics and 3D PAR are game changers because they 'erase' overlying inner retinal blood vessel artifacts allowing for better visualization and more accurate measurement of the outer retina and choroidal structures, essential in treating the abnormal blood vessel growth (CNV membrane) that leads to blindness for patients with wet age-related macular degeneration (AMD),” said Paul E. Tornambe, M.D., F.A.C.S., with Retinal Consultants of San Diego. “In the past, we’ve relied on two-dimensional imaging to determine the presence or absence of fluid leaking from these abnormal vessels in the retina, and whether or not additional treatment is necessary with VEGF inhibitor drugs.

Optovue First to Release High Density OCT Angiography for Ophthalmology

AngioVueHD Enhances Image Resolution Over Extended Field-of-View Optovue, the global leader in the development of optical coherence tomography...